telmisartan has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arthur, P; Gebeyehu, A; Kalvala, AK; Mondal, A; Nottingham, E; Patel, N; Rishi, AK; Singh, M; Surapaneni, SK | 1 |
| Arthur, P; Bagde, A; Gebeyehu, A; Kutlehria, S; Mondal, A; Nottingham, E; Patel, N; Singh, M; Surapaneni, SK | 1 |
2 other study(ies) available for telmisartan and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Telmisartan Facilitates the Anticancer Effects of CARP-1 Functional Mimetic and Sorafenib in Rociletinib Resistant Non-small Cell Lung Cancer.
Topics: Acrylamides; Animals; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Nude; Pyrimidines; Sorafenib; Spheroids, Cellular; Spiro Compounds; Telmisartan; Thiadiazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Targeting lung cancer stem cells using combination of Tel and Docetaxel liposomes in 3D cultures and tumor xenografts.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Culture Techniques; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Female; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Telmisartan; Xenograft Model Antitumor Assays | 2020 |